Qube Research & Technologies LTD Ocular Therapeutix, Inc Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$4.83 - $7.35 $377,908 - $575,078	-78,242 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$6.16 - $12.07 $287,160 - $562,667	46,617 Added 147.41%	78,242 $545,000
Q3 2021 Nov 12, 2021	SELL	$9.7 - $14.34 $633,856 - $937,061	-65,346 Reduced 67.39%	31,625 $316,000
Q2 2021 Aug 13, 2021	BUY	$13.43 - $19.16 $1.02 Million - $1.46 Million	76,202 Added 366.9%	96,971 $1.38 Million
Q1 2021 May 14, 2021	BUY	$15.82 - $22.11 $328,565 - $459,202	20,769 New	20,769 $341,000

Q3 2020 Nov 12, 2020	SELL	$7.36 - $9.87 $326,408 - $437,724	-44,349 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $207,109 - $396,923	44,349 New	44,349 $369,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.